Scilight Press

Author Information

Received: 15 Oct 2022 | Accepted: 21 Nov 2022 | Published: 21 Dec 2022

Abstract

Graphical Abstract

Image Viewer

Open in new tab

Download Image

Keywords

myocardial infarction | drug delivery | nanoparticles

References 

• 1.
  Nichols M.; Townsend N.; Scarborough P.; et al. Cardiovascular disease in Europe 2014: epidemiological update. Eur. Heart J., 2014, 35(42): 2950-2959.
• 2.
  Reed G.W.; Rossi J.E.; Cannon C.P. Acute myocardial infarction. Lancet, 2017, 389(10065): 197-210.
• 3.
  Marín-Juez R.; El-Sammak H.; Helker C.S.M.; et al. Coronary revascularization during heart regeneration is regulated by epicardial and endocardial cues and forms a scaffold for cardiomyocyte repopulation. Dev. Cell, 2019, 51(4): 503-515.e4.
• 4.
  Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat. Rev. Cardiol., 2020, 17(12): 773-789.doi:10.1038/s41569-020-0403-y.
• 5.
  Yang L.Q.; Peng J.J.; Shi A.P.; et al. Myocardium-targeted micelle nanomedicine that salvages the heart from ischemia/reperfusion injury. ACS Appl. Mater. Interfaces, 2022, 14(34): 38562-38574.
• 6.
  Chen J.L.; Huang N.; Ma B.L.; et al. Guidance of stem cells to a target destination in vivo by magnetic nanoparticles in a magnetic field. ACS Appl. Mater. Interfaces. 2013, 5(13): 5976-5985.
• 7.
  Bahadur S.; Sachan N.; Harwansh R.K.; et al. Nanoparticlized system: promising approach for the management of alzheimer’s disease through intranasal delivery. Curr. Pharm. Des., 2020, 26(12): 1331-1344.
• 8.
  Pala R.; Anju V.T.; Dyavaiah M.; et al. Nanoparticle-mediated drug delivery for the treatment of cardiovascular diseases. Int. J. Nanomed., 2020, 15: 3741-3769.
• 9.
  Pan Q.; Xu J.; Wen C.J.; et al. Nanoparticles: promising tools for the treatment and prevention of myocardial infarction. Int. J. Nanomed., 2021, 16: 6719-6747.
• 10.
  Saikia C.; Das M.K.; Ramteke A.; et al. Effect of crosslinker on drug delivery properties of curcumin loaded starch coated iron oxide nanoparticles. Int. J. Biol. Macromol., 2016, 93(Pt A): 1121-1132.
• 11.
  Malekzadeh A.M.; Ramazani A.; Rezaei S.J.T.; et al. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy. J. Colloid Interface Sci., 2017, 490: 64-73.
• 12.
  Prabhakar U.; Maeda H.; Jain R.K.; et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res., 2013, 73(8): 2412-2417.
• 13.
  Suarez S.; Almutairi A.; Christman K.L. Micro- and nanoparticles for treating cardiovascular disease. Biomater. Sci., 2015, 3(4): 564-580.
• 14.
  Nguyen M.M.; Carlini A.S.; Chien M.P.; et al. Enzyme-responsive nanoparticles for targeted accumulation and prolonged retention in heart tissue after myocardial infarction. Adv. Mater., 2015, 27(37): 5547-5552.
• 15.
  Lu A.H.; Salabas E.L.; Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed., 2007, 46(8): 1222-1244.
• 16.
  Arias L.S.; Pessan J.P.; Vieira A.P.M.; et al. Iron oxide nanoparticles for biomedical applications: a perspective on synthesis, drugs, antimicrobial activity, and toxicity. Antibiotics, 2018, 7(2): 46.
• 17.
  Cheng M.; Yang J.J.; Zhao X.Q.; et al. Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells. Nat. Commun., 2019, 10(1): 959.
• 18.
  Cheng K.; Shen D.L.; Hensley M.T.; et al. Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting. Nat. Commun., 2014, 5: 4880.
• 19.
  Liu S., Chen X. , Bao L.;et al., Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles. Nat. Biomed. Eng., 2020 4(11) 1063-1075.
• 20.
  Théry C.; Zitvogel L.; Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol., 2002, 2(8): 569-579.
• 21.
  Kowal J., Arras G., Colombo M.; et al., Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc. Natl. Acad. Sci. USA, 113 (2016) E968-77.
• 22.
  Han Z.; Liu S.Q.; Pei Y.G.; et al. Highly efficient magnetic labelling allows MRI tracking of the homing of stem cell-derived extracellular vesicles following systemic delivery. J. Extracell. Vesicles, 2021, 10(3): e12054.
• 23.
  Busato A.; Bonafede R.; Bontempi P.; et al. Magnetic resonance imaging of ultrasmall superparamagnetic iron oxide-labeled exosomes from stem cells: a new method to obtain labeled exosomes. Int. J. Nanomed., 2016, 11: 2481-2490.
• 24.
  Li H.; Zhu J.; Xu Y.W.; et al. Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction. Redox. Biol., 2022, 54: 102384.
• 25.
  Wu X.X.; Liu L.; Zheng Q.L.; et al. Protocatechuic aldehyde protects cardiomycoytes against ischemic injury via regulation of nuclear pyruvate kinase M2. Acta Pharm. Sin. B, 2021, 11(11): 3553-3566.